NVDA
NVIDIA Corporation
NVDA has the edge over PCOR overall, supported by stronger valuation and stronger modeled upside.
PCOR
Procore Technologies, Inc.
PCOR's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PCOR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Weak |
PCOR's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is weak.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PCOR PE Valuation
PCOR has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PCOR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
PCOR has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over PCOR on earnings quality, reporting a profit while its opponent remains loss making.
PCOR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.23 | — |
| Q3 2026 | -$0.23 | +$0.61 |
| Q2 2026 | -$0.26 | +$0.70 |
| Q1 2026 | -$0.51 | +$0.35 |
| Q4 2025 | -$0.67 | +$0.05 |
| Q3 2025 | -$0.84 | -$0.33 |
| Q2 2025 | -$0.96 | -$0.32 |
| Q1 2025 | -$0.86 | +$0.11 |
| Q4 2024 | -$0.72 | +$0.62 |
PCOR is still losing money, but far less than before: $0.23 per share over the past year, against $2.94 at its worst in late 2021.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PCOR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PCOR on profitability, with a higher operating margin.
PCOR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $402.3M | +19% |
| Q2 2026 | $375.2M | +16% |
| Q1 2026 | $359.3M | +16% |
| Q4 2025 | $349.1M | +16% |
| Q3 2025 | $338.9M | +15% |
| Q2 2025 | $323.9M | +14% |
| Q1 2025 | $310.6M | +15% |
| Q4 2024 | $302M | +16% |
PCOR's revenue has grown year over year every quarter since late 2020: $402M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.8% | +2.7 points |
| Q2 2026 | 1.1% | +11 points |
| Q1 2026 | -4.4% | +7.3 points |
| Q4 2025 | -12% | +9.7 points |
| Q3 2025 | -4.4% | +7.9 points |
| Q2 2025 | -9.3% | -4.1 points |
| Q1 2025 | -12% | -4.7 points |
| Q4 2024 | -22% | -7.6 points |
PCOR's operating margin was −1.8% last quarter, up 2.7 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PCOR on cash flow, with more consistent year-over-year improvement.
PCOR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.5M | +10% |
| Q2 2026 | $80.9M | +190% |
| Q1 2026 | $73.8M | +19% |
| Q4 2025 | $109.2M | +527% |
| Q3 2025 | $83.1M | +133% |
| Q2 2025 | $27.9M | -51% |
| Q1 2025 | $62M | -7.5% |
| Q4 2024 | $17.4M | -55% |
PCOR generated $355M in free cash flow over the past year, up 87% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over PCOR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PCOR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -2.4M shares |
| 1 year | +0.1% | +104K shares |
| 3 years | +5.3% | +7.6M shares |
| 5 years | +104% | +76.8M shares |
| Available history | +28% | +32.7M shares |
PCOR has 150M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $175M |
| Q2 2026 | — |
| Q1 2026 | $100M |
| Q4 2025 | $23,000 |
| Q3 2025 | $25.7M |
| Q2 2025 | $3.1M |
| Q1 2025 | $100M |
| Q1 2021 | — |
PCOR spent $275M buying back its own shares over the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over PCOR on leverage, with a lower net debt burden relative to earnings.
PCOR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.5x | High |
| Q2 2026 | -10.5x | Net Cash |
| Q1 2026 | -42.3x | Net Cash |
PCOR's net debt is about 6.5 years of its operating earnings (EBITDA).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PCOR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.9 | Neutral |
| Stochastic | 87.5 | Overbought |
PCOR's weekly RSI is 69 (neutral) and its Stochastic is 87 (overbought).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PCOR PE vs Technology Sector
PCOR has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
PCOR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.3 | 26% above |
| 20 week MA | $56.4 | 37% above |
| 50 week MA | $56.9 | 36% above |
| 100 week MA | $64.0 | 21% above |
| 200 week MA | $64.7 | 19% above |
PCOR has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
PCOR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $88.6 | $81.7 | -7.8% |
| 2022 | $81.7 | $47.9 | -41% |
| 2023 | $47.9 | $69.2 | +44% |
| 2024 | $69.2 | $76.4 | +10% |
| 2025 | $76.4 | $74.5 | -2.4% |
| 2026 YTD | $74.5 | $77.2 | +3.6% |
PCOR has the edge over NVDA on returns for 2026, with the stronger performance.